Cost-effectiveness analysis of subcutaneous biosimilar tocilizumab in patients with rheumatoid arthritis in Spain

1. Pérez-Ruiz, F.
2. Crespo-Diz, C.
3. Schoenenberger-Arnaiz, J.A.
4. Cerezales, M.
5. Crespo, C.
6. Guigini, M.A.
7. Peinado-Fabregat, J.I.
8. Climente-Martí, M.

Exportar

Exportar ×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Exportar ×

Non se pode exportar o documento porque pertence a outro portal.

Texto completo

lock_openTexto completo externo

DOI: 10.1016/J.FARMA.2025.02.006 GOOGLE SCHOLAR lock_openAcceso aberto editor

Fonte de datos: Scopus